Abstract
Methods: Using PCR-RFLP analysis we analysed a -1082G/A single nucleotide polymorphism (SNP) of the anti-inflammatory IL-10 gene, a -308G/A SNP of the pro-inflammatory TNF-α gene and a -174G/C SNP of the IL-6 gene. Illness severity was stratified according to SIRS score, calculated by presence of up to four physiological indices: temperature, white blood cell count, heart rate and respiratory rate (non-SIRS, SIRS 2, SIRS 3, and SIRS 4).
Results: A statistically significant stepwise increase in frequency of the IL-10 G allele, associated with higher expression of the gene, was observed in patients with increasing severity of illness from non-SIRS (n=19) to SIRS 2 (n=17), SIRS 3 (n=33) and SIRS 4 (n=24). This was primarily due to a higher frequency of the GG genotype with increasing severity from non-SIRS through to SIRS 4. IL-10 G allele frequency was also increased in patients who died as a result of CAP (n=11) compared with CAP survivors (n=82) (p=0.01). No association was seen between the TNF-α -308G/A and IL-6 -174G/C SNPs and disease. Additionally, no interaction between all three SNP genotypes and disease severity was observed.
Conclusions: A polymorphism affecting IL-10 expression may influence the severity of illness in patients with CAP.
Full Text
The Full Text of this article is available as a PDF (116.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens. 1997 Jun;49(6):635–639. doi: 10.1111/j.1399-0039.1997.tb02812.x. [DOI] [PubMed] [Google Scholar]
- Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J. S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998 Oct 1;102(7):1369–1376. doi: 10.1172/JCI2629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glynn P., Coakley R., Kilgallen I., Murphy N., O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax. 1999 Jan;54(1):51–55. doi: 10.1136/thx.54.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kroeger K. M., Carville K. S., Abraham L. J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997 Apr;34(5):391–399. doi: 10.1016/s0161-5890(97)00052-7. [DOI] [PubMed] [Google Scholar]
- Rangel-Frausto M. S., Pittet D., Costigan M., Hwang T., Davis C. S., Wenzel R. P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995 Jan 11;273(2):117–123. [PubMed] [Google Scholar]
- Sfeir T., Saha D. C., Astiz M., Rackow E. C. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med. 2001 Jan;29(1):129–133. doi: 10.1097/00003246-200101000-00026. [DOI] [PubMed] [Google Scholar]
- Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J., Hutchinson I. V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997 Feb;24(1):1–8. doi: 10.1111/j.1365-2370.1997.tb00001.x. [DOI] [PubMed] [Google Scholar]
- van der Poll T., de Waal Malefyt R., Coyle S. M., Lowry S. F. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis. 1997 Jan;175(1):118–122. doi: 10.1093/infdis/175.1.118. [DOI] [PubMed] [Google Scholar]